nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bibliometric analysis of cancer research funders and collaborators in Kenya: 2007–2017
|
Vargas, Jasmin S. |
|
|
33 |
C |
p. |
artikel |
2 |
A comparative study of cancer drug approvals in india and high-income countries
|
Roy, Arya Mariam |
|
|
33 |
C |
p. |
artikel |
3 |
Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence
|
Freeman, Victoria |
|
|
33 |
C |
p. |
artikel |
4 |
Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registries
|
Créquit, Perrine |
|
|
33 |
C |
p. |
artikel |
5 |
Choosing Wisely Africa: Insights from the front lines of clinical care
|
Rubagumya, Fidel |
|
|
33 |
C |
p. |
artikel |
6 |
Corrigendum to “Oral cancer awareness and knowledge: Survey of dentists in Democratic Republic of the Congo” [J. Cancer Policy 32 (2022) 100332]
|
Fidele, Nyimi Bushabu |
|
|
33 |
C |
p. |
artikel |
7 |
Economic burden of cancer attributable to overweight in the Brazilian Unified Health System
|
de Carvalho, Joana Brant |
|
|
33 |
C |
p. |
artikel |
8 |
Effect of municipal and state regulation on access and outcomes for cervical cancer patients in Rio de Janeiro, Brazil: An interrupted time series analysis
|
Faria, Lara Vinhal |
|
|
33 |
C |
p. |
artikel |
9 |
Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trials
|
Cooper, Ryan A. |
|
|
33 |
C |
p. |
artikel |
10 |
Game changer in cancer treatment in Switzerland
|
Lomazzi, M. |
|
|
33 |
C |
p. |
artikel |
11 |
Immune checkpoint inhibitors for the treatment of non-small cell lung cancer: A comparison of the regulatory approvals in Europe and the United States
|
Zaim, Remziye |
|
|
33 |
C |
p. |
artikel |
12 |
Practicalities, challenges and solutions to delivering a national organisational survey of cancer service and processes: Lessons from the National Prostate Cancer Audit
|
Dodkins, Joanna |
|
|
33 |
C |
p. |
artikel |
13 |
Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer
|
Henderson, Raymond H. |
|
|
33 |
C |
p. |
artikel |
14 |
The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence
|
Carle, Chelsea |
|
|
33 |
C |
p. |
artikel |